A set of reagents for enzyme-linked immunosorbent assay determination of the concentration of chorionic gonadotropin in blood serum (HCG-ELISA-BEST) according to TU 9398-190-23548172-2009
Russia·Unknown·CJSC Vector-Best·Registered June 24, 2009·Class 2a- Device Name (English)
- A set of reagents for enzyme-linked immunosorbent assay determination of the concentration of chorionic gonadotropin in blood serum (HCG-ELISA-BEST) according to TU 9398-190-23548172-2009
- Device Name (Russian)
- Набор реагентов для иммуноферментного определения концентрации хорионического гонадотропина в сыворотке крови (ХГЧ-ИФА-БЕСТ) по ТУ 9398-190-23548172-2009
- Device Type (English)
- N/A
- Device Type (Russian)
- Unknown
- Risk Class
- Class 2a
- OKPD Code
- 93 9817
- Registry Key
- o2680
- Registration Number
- ФСР 2009/05146
- Registration Date
- June 24, 2009
- Validity Period
- April 13, 2016
- Manufacturer Name (English)
- CJSC Vector-Best
- Manufacturer Name (Russian)
- ЗАО Вектор-Бест
- Country (English)
- Russia
- Country (Russian)
- Россия
- Legal Address (English)
- Russia 630559 Novosibirsk region, Novosibirsk district, Koltsovo, ABK
- Legal Address (Russian)
- Россия 630559 Новосибирская область Новосибирский район п.Кольцово АБК
Access comprehensive regulatory information for A set of reagents for enzyme-linked immunosorbent assay determination of the concentration of chorionic gonadotropin in blood serum (HCG-ELISA-BEST) according to TU 9398-190-23548172-2009 in the Russia medical device market through Pure Global AI's free database. This Class 2a medical device is registered under Roszdravnadzor registration number ФСР 2009/05146 and manufactured by CJSC Vector-Best. The device was registered on June 24, 2009.
This page provides complete registration details including device type, manufacturer information, country of origin (Russia), and regulatory compliance data from the official Russia Roszdravnadzor medical device database. Pure Global AI offers free access to Russia's complete medical device registry, helping global MedTech companies navigate Roszdravnadzor regulations efficiently.